Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Indegene has informed that it enclosed the copy of Press Release titled ‘Indegene Receives Frost & Sullivan’s 2026 Global Enabling Technology Leadership Recognition for AI-Powered Pharma Commercialization’. This will also be posted on the company’s website at: https://www.indegene.com/.
The above information is a part of company’s filings submitted to BSE.